Locked-in capital, robust fees and dry powder should help firms ride out market stress
Recession fears and inflation weigh on activity, a KPMG report says
The acquisition adds to CI's ultra-high-net-worth business
Deal volume ticked up, value surged on mega-deal strength
Much of the portfolio is focused on the technology and life science sectors
Toronto-based firm sold 20% stake in U.S. business in May
Regulatory, financial and economic headwinds all weigh on deal activity
The bank said it's committed to its 2023 strategy and fiscal priorities while the review takes place
Finance extended the consultation period by 15 days to July 21
The US$4.3-billion deal is expected to close in the first half of 2024